跳至主要内容
临床试验/ISRCTN07329370
ISRCTN07329370已完成4 期

An open-label study of intra-articular steroid injection in the management of symptomatic knee osteoarthritis

Salford Royal NHS Foundation Trust (UK)0 个研究点目标入组 120 人开始时间: 2010年5月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 40 - 79 years
  • 2. Male or female
  • 3. Ambulatory (not wheelchair bound)
  • 4. Able and willing to attend or comply with intervention and follow up
  • 5. Within the last 24 months:
  • 5.1. Radiological (X-ray) evidence of grade 2 or more OA
  • 5.2. Evidence of significant OA on MRI scan
  • 5.3. Documented evidence of at least grade 2 arthritis on arthroscopy
  • 6. Moderate knee pain lasting 48 hours in the past 2 weeks
  • 7. Presence of clinically apparent knee effusion
  • 8. Written informed consent
  • 9. Glomerular filtration rate (GFR) greater than 44 ml/min

排除标准

  • 1. Secondary OA - septic arthritis, gout
  • 2. History of inflammatory arthritis
  • 3. Previous intra-articular Ostenil or steroid injection within 6 months
  • 4. Previous knee surgery (including cartilage surgery) or arthroscopy within 6 months
  • 5. Inability to understand the procedures
  • 6. Pregnancy
  • 7. Chronic kidney disease with estimated glomerular filtration rate (eGFR) greater than or equal to 44 ml/min
  • 8. Concurrent life threatening illness
  • 9. Implants which prohibit safe use of MRI scan including cochlear implants/metal objects in the body including joint prosthesis, cardiac or neural pacemakers, hydrocephalus shunts, intrauterine device or coil
  • 10. Known hypersensitivity to Depomedrone or any components of its excipients
  • 11. Systemic infection (unless specific anti infective therapy is employed)

研究者

发起方
Salford Royal NHS Foundation Trust (UK)

相似试验